🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, randomized, open-label, multi-center study evaluating t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01137994
Treatments Being Tested
This study is an open-label, dose-escalation study of MM-111 with five diff...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2011-01
Trial ID
NCT01304784
The purpose of this study is to determine the optimally-tolerated regimens ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-12-07
Trial ID
NCT00367471
Treatments Being Tested
This was a four-arm (parallel group) randomized, open-label, multicenter Ph...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-05-16
Trial ID
NCT00490139
Treatments Being Tested
This study will examine safety and efficacy of Lapatinib in combination wit...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08
Trial ID
NCT00524303
Treatments Being Tested
This Study was designed to determine how effective and safe a new investiga...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00111787
Treatments Being Tested
Pazopanib will be given with TAXOL in one part, in another part pazopanib w...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-28
Trial ID
NCT00388076
Treatments Being Tested
This study investigates the safety and efficacy of oral lapatinib in combin...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00356811
Treatments Being Tested
The Neo-PREDICT-HER2 Study is phase II trial to validate predictive markers...
Status
Terminated
Location
Klinikum Esslingen
Start Date
2013-09-30
Trial ID
NCT01891357
Treatments Being Tested
This was an open-label, single-arm, multi-center, Phase II study to determi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-07-02
Trial ID
NCT00709761
Treatments Being Tested